Rapport Therapeutics to Participate in Upcoming Investor Conferences
Globe Newswire•03/11/2026•07:00 ET
0
Key Highlights
- ➤Rapport Therapeutics (RAPP) will participate in two November investor conferences
- ➤Stifel conference fireside chat scheduled for November 11, 2026
- ➤Jefferies conference presentation and fireside chat scheduled for November 16, 2026
- ➤RAP-219 advances in epilepsy and bipolar mania late-stage programs
BOSTON and SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological and psychiatric disorders, today announced that management will participate in two upcoming investor conferences.
Stifel 2026 Healthcare Conference (New York City, NY) Fireside chat on Wednesday, November 11, 2026, at 1:20 – 1:50 p.m. ET.
Get started
Create a free account to read the full story.